Eli Lilly's obesity drug beats rival in head-to-head trial — where Cramer sees shares going next

1 month ago 20

ARTICLE AD BOX

A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana.

Scott Olson | Getty Images

New trial data has cemented Club holding Eli Lilly's pole position in the highly competitive obesity drug race.

Read Entire Article